Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.410
-0.930 (-17.42%)
Mar 31, 2025, 4:08 PM HKT

HKG:2563 Statistics

Total Valuation

HKG:2563 has a market cap or net worth of HKD 1.61 billion. The enterprise value is 1.06 billion.

Market Cap 1.61B
Enterprise Value 1.06B

Important Dates

The next estimated earnings date is Friday, June 27, 2025.

Earnings Date Jun 27, 2025
Ex-Dividend Date n/a

Share Statistics

HKG:2563 has 364.59 million shares outstanding.

Current Share Class 216.72M
Shares Outstanding 364.59M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.99%
Owned by Institutions (%) 5.99%
Float 131.18M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 21.90
PB Ratio 2.02
P/TBV Ratio 2.02
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -5.10
EV / Sales 14.50
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -5.46

Financial Position

The company has a current ratio of 14.48, with a Debt / Equity ratio of 0.00.

Current Ratio 14.48
Quick Ratio 13.53
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF -0.01
Interest Coverage -3,797.81

Financial Efficiency

Return on equity (ROE) is -23.84% and return on invested capital (ROIC) is -16.98%.

Return on Equity (ROE) -23.84%
Return on Assets (ROA) -15.93%
Return on Invested Capital (ROIC) -16.98%
Return on Capital Employed (ROCE) -29.71%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.08
Inventory Turnover 0.68

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 9.83
200-Day Moving Average n/a
Relative Strength Index (RSI) 9.05
Average Volume (20 Days) 57,600

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2563 had revenue of HKD 73.41 million and -208.93 million in losses. Loss per share was -0.60.

Revenue 73.41M
Gross Profit 51.59M
Operating Income -238.48M
Pretax Income -208.93M
Net Income -208.93M
EBITDA -228.38M
EBIT -238.48M
Loss Per Share -0.60
Full Income Statement

Balance Sheet

The company has 634.58 million in cash and 990,404 in debt, giving a net cash position of 633.59 million or 1.74 per share.

Cash & Cash Equivalents 634.58M
Total Debt 990,404
Net Cash 633.59M
Net Cash Per Share 1.74
Equity (Book Value) 796.69M
Book Value Per Share 2.28
Working Capital 649.75M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -164.51 million and capital expenditures -30.67 million, giving a free cash flow of -195.19 million.

Operating Cash Flow -164.51M
Capital Expenditures -30.67M
Free Cash Flow -195.19M
FCF Per Share -0.54
Full Cash Flow Statement

Margins

Gross margin is 70.27%, with operating and profit margins of -324.87% and -284.60%.

Gross Margin 70.27%
Operating Margin -324.87%
Pretax Margin -284.60%
Profit Margin -284.60%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:2563 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -12.99%
FCF Yield -12.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2